🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Hairy Cell Leukemia (HCL)

Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management NCT06774677n/a3 sites📍 Palermo📍 Siena📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Therapy Optimisation for the Treatment of Hairy Cell Leukemia NCT02131753Phase 2, Phase 376 sites📍 Ansbach📍 Aschaffenburg📍 Bad Neustadt an der Saale University of Giessen · Tests: Cladribine s.c. injection, HCL treatment Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia NCT06965114Phase 1, Phase 24 sites📍 Bethesda📍 Columbus📍 Pittsburgh National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cladribine, Computed Tomography Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant NCT04322383Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: binimetinib Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment NCT01087333n/a1 site📍 Bethesda National Cancer Institute (NCI) Assessment of Disease Burden in Hairy Cell Leukemia NCT06781515NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Peripheral and BM blood sample AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas NCT06340737Phase 11 site📍 Palo Alto Stanford University · Tests: CD22CART Infusion Hairy Cell Leukemia Patient Data Registry NCT02560883n/a8 sites📍 Miami📍 Miami Beach📍 Rochester Ohio State University Comprehensive Cancer Center A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL) NCT06561360Phase 210 sites📍 Boston📍 Rochester📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Vemurafenib, Obinutuzumab, Cladribine, Rituximab Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia NCT00412594Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cladribine, Laboratory Biomarker Analysis, Rituximab Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies. NCT04775745Phase 14 sites📍 Durham📍 Cincinnati📍 Columbus Newave Pharmaceutical Inc · Tests: LP-168, LP-168 Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management NCT06764524n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant NCT04815356Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: CD22CART cell infusion
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy